Zdrowie i gospodarka · 01/03/2006
FDA Corrects Final Rule on Hepatitis A Virus Serological Assays
The Food and Drug Administration (FDA) is revising a 2006 rule that incorrectly reclassified hepatitis A virus (HAV) serological assays, correcting the mistake to reflect the correct classification as class II (special controls).
Source: Federal Register — Food and Drug AdministrationOpen original release →